Gene Query: PADI3

Dataset Description Geneva Score
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 155.01
Silencing p300 in MCF7 cells to study expression and alternative splicing 135.3
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 86.61
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 81.4
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 78.08
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 75.9
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 73.86
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 39.76
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 32.65
RNA expression analysis upon JMJD1C depletion 32.21
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 32.21
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 26.54
Transcriptomic analysis of frontal fibrosing alopecia 23.97
RNA sequencing of human pancreatic cancer cell lines 18.43
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 17.8
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 17.65
G-quadruplex structures mark human regulatory chromatin 17.29
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 16.58
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 16.45
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 16.45
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 16.29
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 16.07
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 14.23
Expression data from miR340 overexpressing human A549 cells 14.2
Transcriptome profiling of Normal and Cancerous Prostate Cells 14.0
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 13.0
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.86
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 12.86
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.44
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 12.38
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 12.04
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 11.66
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 11.34
IRF2 is a master regulator of human keratinocyte stem cell fate 11.3
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 11.3
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 11.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 10.96
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 10.96
CSL 10.94
CSL RNA-Seq on HKC and SCC cell lines 10.94
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 9.81
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 9.68
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 9.68
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 9.5
H1609088 Human RNA-Sequencing 9.4
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 8.93
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 8.69
mRNA sequencing of oropharyngeal cancer cell lines 8.65
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 8.63
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 8.28
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 8.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 7.91
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.78
TGF-β promotes genomic instability after loss of RUNX3 7.39
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 7.18
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 6.64
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 6.62
circRNA profile in hypopharyngeal cancer 6.54
Nrf2 regulated genes in A549 cells 6.12
Identification of Nrf2 regulated genes by RNA sequencing 6.12
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 6.08
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 5.73
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 5.7
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 5.19
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 5.14
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.59
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.58
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.58
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 4.54
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 4.54
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 4.54
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 4.22
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.05
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.75
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.73
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.64
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.62
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.62
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.6
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.6
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 3.55
Overexpression of NFIB and YBX1 in MCF-7 cells 3.48
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.46
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 3.45
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.44
Gene expression analysis of breast cancer cell-lines 3.44
RNA m5C Methylation in breast cancer using MeRIP-Seq 3.28
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.27
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.27
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.0
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.93
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.93
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.93
Expression profiling of converted and control dermal BJ fibroblasts 2.93
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.84
Fusion discovery in breast cancer cell line 2.82
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.79
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.75
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.72
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 2.7
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.65
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.58
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.58
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 2.56
RNA seq comparison between scrambled and shGRP78 cells 2.55
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.55
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.44
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.42
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.23
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 2.22
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 2.19
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.0
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 1.97
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.89
Analysis of transcriptional regulation by Myt1 and Myt1l 1.87
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.87
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 1.85
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.8
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.79
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 1.74
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.73
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.73
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.69
Rorc disruption in human FG pancreatic cancer cells 1.68
TGF-β regulation of miRNA expression in pancreatic cancer 1.57
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 1.53
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.52
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 1.52
T47D RNA-seq and ChrRNA-seq data 1.52
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.52
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.48
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.44
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.4
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.4
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.38
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.33
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 1.33
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.32
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.32
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.3
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.28
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.28
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 1.22
A prostate cancer chromatin interaction map 1.2
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.19
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.19
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.19
Transcriptome analysis of U87 cells upon LINC00152 knockdown 1.14
Gene expression profile in breast cancer cell lines using RNA sequencing 1.07
RNA-seq of IL-4 stimulated human keratinocytes 1.04
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.03
Transcriptome of U251 cells overexpression complement component 7 1.02
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 1.0
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.99
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.99
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.98
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.98
ML29755 RNA-seq data 0.97
Investigate A2M treatment on human prostate cancer and mouse liver 0.97
Investigate A2M treatment on human prostate cancer xenograft in mice 0.97
MCF10A H-Ras RNA-Seq 0.97
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.97
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.95
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 0.92
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.88
Exploring ILF2 regulatory genes by next-generation sequencing 0.86
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.85
LncRNA-GAS5 negative regulation of YAP-target genes expression 0.84
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 0.77
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.76
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.75
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.75
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 0.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 0.69
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 0.69
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.69
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.69
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.65
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.65
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.64
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 0.63
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.62
mRNA-sequencing of breast cancer subtypes and normal tissue 0.62
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.62
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 0.62
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.61
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.61
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.6
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.6
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.6
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 0.59
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 0.58
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 0.57
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.57
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.57
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.54
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.54
Illumina Total RNA-seq in HeLa 0.53
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.53
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 0.52
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.52
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.52
Overexpression and knockdown experiment for circCSNK1G3 0.5
NR2F2 study 0.5
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 0.5
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 0.49
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 0.49
RNA-seq analysis and shRNA screen of breast cancer 0.48
RNA-seq analysis of breast cancer 0.48
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.48
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.47
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 0.47
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.46
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.46
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 0.46
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.45
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 0.45
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 0.43
FOXP1 orchestration of ASD-relevant signaling pathways. 0.42
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 0.42
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 0.42
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.42
TCF7L1 knockdown in pancreatic cancer 0.42
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.41
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.41
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.41
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 0.4
Functional role of CPPED1 in trophoblasts. 0.4
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 0.39
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 0.39
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.38
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.37
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.37
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.37
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.37
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.37
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 0.36
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.35
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.35
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.35
A role for ZNF598 in post-transcriptional gene regulation 0.35
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.35
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.35
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.35
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.34
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.34
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.34
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.33
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.33
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 0.33
Dynamic 3D chromosomal landscapes in acute leukemia 0.33
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.33
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.33
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 0.32
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.32
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.32
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.32
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.31
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.31
Identification of long noncoding RNAs regulated by p53 0.3
RNA-seq analysis to identify the genes regulated by p53-SET interplay 0.3
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 0.28
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 0.28
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.28
Interphase condensins regulate ligand-depedent enhancer activation 0.28
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 0.28
Human embryonic stem cells in E8 and AKIT culture medium 0.28
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.27
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 0.27
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 0.27
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.26
RNA editing in nascent RNA affects pre-mRNA splicing 0.26
Gene expression of collecting duct carcinoma of the kidney 0.26
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.26
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.26
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 0.26
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.26
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 0.26
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.25
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.25
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.25
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.24
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.24
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.24
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.24
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.23
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 0.23
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 0.23
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.23
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.23
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.22
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.22
BAF controls genome accessibility 0.22
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 0.22
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 0.22
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 0.22
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 0.22
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.22
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.22
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.22
Differetially expressed genes after hTR overexpression in U2OS cells 0.22
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 0.21
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.21
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.21
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.21
Searching for target genes of miR-508/509/506/514 in HCT116 cells 0.21
N6-methyladenine DNA Modification in Glioblastoma 0.21
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.21
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 0.21
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.21
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.21
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.2
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.2
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.2
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.2
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.19
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.19
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 0.19
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 0.19
METTL3 promotes translation in human cancer cells 0.19
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.19
RNA-Seq analysis of breast cancer cells after shikonin treatment 0.19
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 0.19
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.18
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.18
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.18
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.18
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.18
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.18
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.17
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 0.17
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 0.17
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 0.17
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.17
Effect of drugs on transcriptomic profiles 0.17
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.17
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.17
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 0.17
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.17
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.17
Genome wide expression change by RNF168 knocking down in MCF-7 cells 0.16
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.16
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 0.16
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 0.16
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 0.16
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 0.16
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.16
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 0.16
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.15
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.15
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.15
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.15
Finding missing proteins from epigenetically manipulated human cells 0.14
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.14
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.14
Patient-derived luminal breast cancer xenografts with progestins 0.14
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 0.14
Preclinical model of obesity and ER-positive breast cancer 0.14
RNA expression following TMPRSS11B overexpression or depletion 0.13
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.13
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.13
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.13
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.13
Hepatosplenic T cell lymphoma 0.13
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.13
RNA-seq in transgenic cells 0.13
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.13
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.12
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.12
Energy Metabolism during Anchorage-Independence 0.12
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.12
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.12
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.12
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.12
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.12
Disruption of the exocyst induces podocyte loss and dysfunction 0.12
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.12
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.12
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.12
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.12
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.12
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 0.11
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.11
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.11
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.11
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 0.11
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.11
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.11
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.11
The gene expression profiles of gallbladder cancer 0.11
IRF1 regulates IFN dependent and independent gene expression 0.11
Epigenome regulation during epidermal lineage commitment 0.1
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.1
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.1
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 0.1
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.1
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 0.1
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.1
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.1
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.09
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.09
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.09
Transcriptional responses of melanoma cells to BRAF inhibition 0.09
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 0.09
PRDM1 inhibits proliferation of human colon cancer organoids 0.09
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.09
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.08
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.08
Genome-wide identification of cancer-specific alternative splicing in circRNA 0.08
HEK293 Heat-shock experiment 0.08
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.08
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.08
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.08
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.08
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 0.08
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.08
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.07
TAF1 is critical for AE driven leukemogenesis 0.07
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.07
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.07
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.07
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.07
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 0.07
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.07
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.07
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.07
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 0.07
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.07
ARID1A and ARID1B loss in HCT116 cells 0.07
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.07
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.07
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.07
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.06
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.06
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.06
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.06
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.06
Gene profiling of human adult and pediatric liver cancer cells 0.06
Effect of nuclear IL-33 on gene expression 0.06
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.05
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.05
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.05
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.05
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 0.05
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.05
Oncogenic MYC induces a dependency on the spliceosome in human cancer 0.05
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 0.05
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.05
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.05
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.05
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.05
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.04
RNA sequencing of mechanically strained NHEKs and control NHEKs 0.04
MCF-7 as a model for functional analysis of breast cancer risk variants 0.04
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.04
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.04
RNAseq analysis of ruxolitinib treated breast cancers 0.04
The circadian transcriptional landscape in primary human mammary epithelial cells 0.04
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.04
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.04
IMP3 regulated gene expression in breast cancer cells 0.03
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.03
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.03
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.03
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.03
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.03
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.03
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.03
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.03
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.03
Characterization of the Merkel cell carcinoma miRNome 0.03
RNAseq of Breast cancer PDX samples 0.03
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.02
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.02
High-throughput sequencing of pluripotent cells 0.02
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.02
Transposon-based construction of strand-specific RNA-seq libraries 0.02
Human ovarian granulosa cell transcriptome 0.02
FOXP2's impact on the primate transcriptome 0.02
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 0.02
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.01
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.01
hnRNP C is a key regulator of protein synthesis in mitosis 0.01
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.01
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 0.01
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.01
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.01
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.0
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.0
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.0
Enhancer activation during EGF response 0.0
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.0
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation